1. Home
  2. VNRX vs SNGX Comparison

VNRX vs SNGX Comparison

Compare VNRX & SNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VolitionRX Limited

VNRX

VolitionRX Limited

BUY

Current Price

$0.17

Market Cap

7.2M

Sector

Health Care

ML Signal

BUY

Logo Soligenix Inc.

SNGX

Soligenix Inc.

BUY

Current Price

$0.36

Market Cap

7.7M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
VNRX
SNGX
Founded
N/A
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.2M
7.7M
IPO Year
2012
2006

Fundamental Metrics

Financial Performance
Metric
VNRX
SNGX
Price
$0.17
$0.36
Analyst Decision
Buy
Analyst Count
5
0
Target Price
★ $13.62
N/A
AVG Volume (30 Days)
★ 1.5M
169.6K
Earning Date
11-12-2026
11-06-2026
Dividend Yield
N/A
N/A
EPS Growth
38.00
★ 57.03
EPS
N/A
★ N/A
Revenue
★ $1,727,384.00
$119,371.00
Revenue This Year
$57.67
N/A
Revenue Next Year
$240.52
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 40.04
N/A
52 Week Low
$0.13
$0.32
52 Week High
$3.26
$3.39

Technical Indicators

Market Signals
Indicator
VNRX
SNGX
Relative Strength Index (RSI) 22.79 24.83
Support Level $0.15 N/A
Resistance Level $0.18 $0.82
Average True Range (ATR) 0.02 0.02
MACD 0.01 0.01
Stochastic Oscillator 0.32 39.05

Price Performance

Historical Comparison
VNRX
SNGX

About VNRX VolitionRX Limited

VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on diagnostics and monitoring.

About SNGX Soligenix Inc.

Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely: The Public Health Solutions business segment includes development programs for RiVax, a ricin toxin vaccine candidate, GX943, a therapeutic candidate for antibiotic resistant and emerging infectious disease and various vaccine programs, including a program targeting filoviruses and CiVax; and The Specialized BioTherapeutics business segment is developing and moving toward potential commercialization of HyBryte, utilizing topical synthetic hypericin activated with safe visible light for the treatment of cutaneous T-cell lymphoma (CTCL).

Share on Social Networks: